|
시장보고서
상품코드
1785177
세계의 정제 코팅 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 폴리머별, 용도별, 기능별, 유형별, 최종 사용자별, 지역별, 시장 경쟁(2020-2030년)Tablet Coating Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Polymer, By Application, By Functionality, By Type, By End User, By Region, & Competition, 2020-2030F |
||||||
정제 코팅 세계 시장 규모는 2024년에 9억 2,052만 달러로 평가되었고, 2030년에는 12억 8,091만 달러에 이르고, CAGR은 5.62%를 나타낼 전망입니다.
세계의 정제 코팅 시장은 경구 약물전달 시스템의 진보, 의약품 및 영양 보조 식품 제조 증가, 치료 성능과 편리성에 대한 환자의 기대의 고조에 추진된 강력한 성장을 특징으로 하여 큰 변혁기를 맞이하고 있습니다. 과거에는 정제의 외관을 향상시키고 맛을 마스킹하는 것을 목표로 하는 2차 공정으로 간주되었던 것이 현재 약물의 기능성, 안정성 및 표적 방출을 최적화하는 중요한 단계가 되었습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 9억 2,052만 달러 |
| 시장 규모 : 2030년 | 12억 8,091만 달러 |
| CAGR 2025-2030년 | 5.62% |
| 급성장 부문 | 아크릴 중합체 |
| 최대 시장 | 북미 |
이 시장은 전통적인 부형제 범주에서 제형 혁신의 전략적 인에이블러로 전환하고 있으며, 서방형 제형, 장용성 제형 및 환자에 맞는 제형의 개발을 지원합니다. 세계의 건강 관리 동향이 만성 질환 관리, 셀프 메디케이션, 개인화 치료로 향하는 중, 기능적 성능, 규제와의 일관성, 가공 효율을 실현하는 코팅 솔루션에 대한 수요는 계속 가속화되고 있습니다.
의약품 및 영양보조식품의 제조활동 성장
엄격한 규제 상황 및 규정 준수 압력
서방형 및 표적 약물 전달 시스템에 대한 수요 급증
Global Tablet Coating market was valued at USD 920.52 Million in 2024 and is expected to reach USD 1280.91 Million by 2030 with a CAGR of 5.62%. The Global Tablet Coating Market is undergoing a significant transformation, characterized by strong growth fueled by advancements in oral drug delivery systems, increased pharmaceutical and nutraceutical manufacturing, and heightened patient expectations for therapeutic performance and convenience. What was once viewed as a secondary process aimed at enhancing tablet appearance and masking taste has now become a critical step in optimizing drug functionality, stability, and targeted release.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 920.52 Million |
| Market Size 2030 | USD 1280.91 Million |
| CAGR 2025-2030 | 5.62% |
| Fastest Growing Segment | Acrylic Polymer |
| Largest Market | North America |
This market is shifting from a traditional excipient category to a strategic enabler of formulation innovation, supporting the development of modified-release, enteric-protected, and patient-tailored dosage forms. As global healthcare trends move toward chronic disease management, self-medication, and personalized therapies, the demand for coating solutions that deliver functional performance, regulatory alignment, and processing efficiency continues to accelerate.
Key Market Drivers
Growing Pharmaceutical and Nutraceutical Manufacturing Activities
As global demand for medications and dietary supplements continues to surge particularly in emerging economies such as India, China, Brazil, and Southeast Asia manufacturers are scaling up production of solid oral dosage forms, especially tablets. China and India collectively account for over 50% of all new drug applications, reflecting the region's rapidly expanding pharmaceutical sector and the growing demand for medications driven by large populations, increasing healthcare access, and rising prevalence of chronic diseases. These high-volume outputs require efficient and high-performance tablet coating systems to ensure product uniformity, protect active pharmaceutical ingredients (APIs), and improve shelf stability. Coatings are no longer just aesthetic; they serve functional roles in ensuring consistent therapeutic performance, especially in climate-sensitive regions. In the pharmaceutical sector, tablet coatings are essential for: Taste masking of bitter APIs, Moisture protection for hygroscopic compounds, Controlled release for improved drug bioavailability, Brand differentiation in a crowded generics market. Similarly, in the nutraceutical space, coatings are used to: Improve visual appeal and consumer acceptance, Enhance swallowability and mask unpleasant tastes or odors, Extend shelf life of active ingredients like probiotics, enzymes, and vitamins.
The proliferation of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) is also contributing to increased coating demand. These service providers are investing in modern, flexible production facilities equipped with automated, high-throughput coating equipment to meet the growing outsourcing needs of pharmaceutical and nutraceutical brands. As CMOs cater to a wide range of clients each with specific formulation, branding, and compliance requirements they rely heavily on versatile coating systems to deliver tailored solutions across various product categories. This is creating a stable and scalable demand base for coating materials and technologies. As pharmaceutical and nutraceutical manufacturers aim to differentiate their products in increasingly saturated markets, coatings provide a low-cost yet high-impact way to enhance product identity through color, texture, and brand-specific finishes. At the same time, coatings support regulatory compliance by: Meeting Good Manufacturing Practice (GMP) standards, Enabling traceability through ink or logo printing on coated tablets, Enhancing dose accuracy and protection for sensitive ingredients. Nutraceutical companies, in particular, are responding to growing consumer demand for clean-label, vegan, and allergen-free products, which is driving adoption of plant-based, TiO2-free coating solutions. As these manufacturers expand production to meet shifting consumer expectations, the coating market sees parallel growth in demand for specialty formulations.
Key Market Challenges
Stringent Regulatory Landscape and Compliance Pressures
One of the foremost challenges is the increasingly complex regulatory environment governing pharmaceutical coatings. Authorities such as the U.S. FDA, EMA, and other national regulatory bodies are imposing tighter scrutiny on excipients, particularly concerning the safety, biocompatibility, and composition of coating materials. The ongoing push to eliminate substances like titanium dioxide (TiO2) and artificial colorants is forcing manufacturers to reformulate existing products to meet new compliance standards. This process involves substantial R&D investment, stability testing, and validation, which can be time-consuming and costly. For smaller players, regulatory hurdles can slow down product development timelines and act as a barrier to entry, thereby constraining overall market growth.
Key Market Trends
Surge in Demand for Modified-Release and Targeted Drug Delivery Systems
As the pharmaceutical industry increasingly prioritizes patient-centric therapies, there is a growing emphasis on modified-release formulations, including sustained, delayed, and targeted release. Tablet coatings play a critical role in these applications, enabling controlled release profiles, site-specific drug delivery (e.g., enteric coatings for intestinal absorption), and protection of active ingredients from gastric degradation. This demand is especially strong in the treatment of chronic conditions such as cardiovascular diseases, diabetes, and neurological disorders, where consistent drug levels and reduced dosing frequency improve therapeutic outcomes and compliance. As a result, pharmaceutical companies are investing in advanced coating technologies that support next-generation drug delivery systems, propelling growth in this segment.
In this report, the Global Tablet Coating Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Tablet Coating Market.
Global Tablet Coating market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: